The University of Queensland

3D Printing for Novel Dosage Form Design

Krueger, Liam, Miles, Jared A. and Popat, Amirali (2023). 3D Printing for Novel Dosage Form Design. AAPS Introductions in the Pharmaceutical Sciences. (pp. 25-44) Cham: Springer International Publishing. doi: 10.1007/978-3-031-34119-9_2

3D printing tablets for high-precision dose titration of caffeine

Krueger, Liam, Cao, Yuxue, Zheng, Zheng, Ward, Jason, Miles, Jared A. and Popat, Amirali (2023). 3D printing tablets for high-precision dose titration of caffeine. International Journal of Pharmaceutics, 642 123132, 1-9. doi: 10.1016/j.ijpharm.2023.123132

seco-pregnane glycosides from Australian caustic vine (Cynanchum viminale subsp. australe)

Xue, Yongbo, Savchenko, Andrei I., Agnew-Francis, Kylie A., Miles, Jared A., Holt, Tina, Lu, Hieng, Chow, Sharon, Forster, Paul I., Boyle, Glen M., Ross, Benjamin P., Fischer, Katja, Kutateladze, Andrei G. and Williams, Craig M. (2023). seco-pregnane glycosides from Australian caustic vine (Cynanchum viminale subsp. australe). Journal of Natural Products, 86 (3), 490-497. doi: 10.1021/acs.jnatprod.2c01037

3D printing hybrid materials using fused deposition modelling for solid oral dosage forms

Krueger, Liam, Miles, Jared A. and Popat, Amirali (2022). 3D printing hybrid materials using fused deposition modelling for solid oral dosage forms. Journal of Controlled Release, 351, 444-455. doi: 10.1016/j.jconrel.2022.09.032

3D printing: potential clinical applications for personalised solid dose medications

Krueger, Liam, Miles, Jared A., Steadman, Kathryn J., Kumeria, Tushar, Freeman, Christopher R. and Popat, Amirali (2022). 3D printing: potential clinical applications for personalised solid dose medications. Medical Journal of Australia, 216 (2), 64-67. doi: 10.5694/mja2.51381

Interaction of opioids with TLR4—mechanisms and ramifications

Gabr, Mai Mahmoud, Saeed, Iqira, Miles, Jared A., Ross, Benjamin P., Shaw, Paul Nicholas, Hollmann, Markus W. and Parat, Marie-Odile (2021). Interaction of opioids with TLR4—mechanisms and ramifications. Cancers, 13 (21) 5274, 5274. doi: 10.3390/cancers13215274

Discovery of drug-like acetylcholinesterase inhibitors by rapid virtual screening of a 6.9 million compound database

Miles, Jared A., Ng, Jia Hui, Sreenivas, B. Yogi, Courageux, Charlotte, Igert, Alexandre, Dias, José, McGeary, Ross P., Brazzolotto, Xavier and Ross, Benjamin P. (2021). Discovery of drug-like acetylcholinesterase inhibitors by rapid virtual screening of a 6.9 million compound database. Chemical Biology and Drug Design, 97 (5), 1048-1058. doi: 10.1111/cbdd.13825

PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral delivery

Raza, Aun, Miles, Jared A., Bruck Sime, Fekade, Ross, Benjamin P., Roberts, Jason A., Popat, Amirali, Kumeria, Tushar and Falconer, James R. (2021). PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral delivery. International Journal of Pharmaceutics, 597 120280, 120280. doi: 10.1016/j.ijpharm.2021.120280

Protein nanoparticles for enhanced oral delivery of coenzyme-Q10: in vitro and in silico studies

Banun, Vanessa Jane, Rewatkar, Prarthana, Chaudhary, Zanib, Qu, Zhi, Janjua, Taskeen, Patil, Anuja, Wu, Yuao, Ta, Hang T., Bansal, Nidhi, Miles, Jared A., Ross, Benjamin P., Kumeria, Tushar and Popat, Amirali (2021). Protein nanoparticles for enhanced oral delivery of coenzyme-Q10: in vitro and in silico studies. ACS Biomaterials Science and Engineering, 9 (6) acsbiomaterials.0c01354, 2846-2856. doi: 10.1021/acsbiomaterials.0c01354

Recent advances in virtual screening for cholinesterase inhibitors

Miles, Jared A. and Ross, Benjamin P. (2021). Recent advances in virtual screening for cholinesterase inhibitors. ACS Chemical Neuroscience, 12 (1) acschemneuro.0c00627, 30-41. doi: 10.1021/acschemneuro.0c00627

Rapid discovery of a selective butyrylcholinesterase inhibitor using structure-based virtual screening

Miles, Jared A., Kapure, Jeevak S., Deora, Girdhar Singh, Courageux, Charlotte, Igert, Alexandre, Dias, José, McGeary, Ross P., Brazzolotto, Xavier and Ross, Benjamin P. (2020). Rapid discovery of a selective butyrylcholinesterase inhibitor using structure-based virtual screening. Bioorganic and Medicinal Chemistry Letters, 30 (24) 127609, 127609. doi: 10.1016/j.bmcl.2020.127609

Rivastigmine and metabolite analogues with putative Alzheimer’s disease-modifying properties in a Caenorhabditis elegans model

Dighe, Satish N., De la Mora, Eugenio, Chan, Stephen, Kantham, Srinivas, McColl, Gawain, Miles, Jared A., Veliyath, Suresh Kumar, Sreenivas, B. Yogi, Nassar, Zeyad D., Silman, Israel, Sussman, Joel L., Weik, Martin, McGeary, Ross P., Parat, Marie-Odile, Brazzolotto, Xavier and Ross, Benjamin P. (2019). Rivastigmine and metabolite analogues with putative Alzheimer’s disease-modifying properties in a Caenorhabditis elegans model. Communications Chemistry, 2 (1) 35. doi: 10.1038/s42004-019-0133-4

Effect of the Biphenyl Neolignan Honokiol on Aβ42-Induced Toxicity in Caenorhabditis elegans, Aβ42 Fibrillation, Cholinesterase Activity, DPPH Radicals, and Iron(II) Chelation

Kantham, Srinivas, Chan, Stephen, McColl, Gawain, Miles, Jared A., Veliyath, Suresh Kumar, Deora, Girdhar Singh, Dighe, Satish N., Khabbazi, Samira, Parat, Marie-Odile and Ross, Benjamin P. (2017). Effect of the Biphenyl Neolignan Honokiol on Aβ42-Induced Toxicity in Caenorhabditis elegans, Aβ42 Fibrillation, Cholinesterase Activity, DPPH Radicals, and Iron(II) Chelation. ACS Chemical Neuroscience, 8 (9), 1901-1912. doi: 10.1021/acschemneuro.7b00071

Discovery of small molecule cholinesterase inhibitors as potential treatments for Alzheimer’s disease using virtual screening

Miles, Jared Adam (2021). Discovery of small molecule cholinesterase inhibitors as potential treatments for Alzheimer’s disease using virtual screening. PhD Thesis, School of Pharmacy, The University of Queensland. doi: 10.14264/ea5f072